Publications & Presentations

The information in our publications and presentations should be considered accurate only as of the date of the publications or presentations. We disclaim any obligation to supplement or update the information in these publications and presentations.

To learn more about our innovative technology:

Publications Presentations

Recurrence Rates for INP104 for the Acute Treatment of Migraine: Results from the Phase 3 STOP 301 Open-Label Study

Poster presented at the 2021 American Headache Society (AHS) Virtual Annual Scientific Meeting. Authors: Stewart J. Tepper, MD, Jessica Ailani, MD, Sheena K. Aurora, MD, Stephen B. Shrewsbury, MB ChB Introduction: Recurrence of migraine headache is common with acute treatment…

Treatment Consistency Across Multiple Migraine Attacks: Results From the Phase 3 Open-Label STOP 301 Study

Poster presented at the 2021 American Headache Society (AHS) Virtual Annual Scientific Meeting. Authors: Richard B. Lipton, MD, Barbara L. Nye, MD, Joe Hirman, PhD, Sheena K. Aurora, MD, and Stephen B. Shrewsbury, MB ChB Introduction: Since people with migraine…

Cardiovascular Safety Results of INP104 (POD-DHE) from the STOP 301 Phase 3 Study

Poster presented at the 2021 American Headache Society (AHS) Virtual Annual Scientific Meeting. Authors: Craig KL, Hoekman J, Jeleva M, Hocevar-Trnka J, Aurora SK, Shrewsbury SB Introduction: DHE product labels warn of potential cardiovascular (CV) and peripheral ischemic events despite…

1 2 3